eNews
Home page > Comments


Comments

German body questions InterMune drug, shares drop

16.12.2011. | (Reuters) - Shares of InterMune Inc fell as much as 30 percent on Thursday, after a German advisory body raised questions on the clinical benefits of its lung drug Esbriet, raising concerns about reimbursement for the drug....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: